Literature DB >> 15765791

Thromboprophylaxis with reviparin in a patient with acquired hemophilia.

Antonio De Giorgi, Chiara Giannarelli, Ferdinando De Negri, Franco Carmassi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15765791     DOI： 10.1532/ijh97.e0408

Source DB:  PubMed          Journal:  Int J Hematol        ISSN： 0925-5710            Impact factor:   2.490


× No keyword cloud information.
  5 in total

Review 1.  Reviparin sodium - a new low molecular weight heparin.

Authors:  Hans Klaus Breddin
Journal:  Expert Opin Pharmacother       Date:  2002-02       Impact factor: 3.889

2.  A prospective study of treatment of acquired (autoimmune) factor VIII inhibitors with high-dose intravenous gammaglobulin.

Authors:  R S Schwartz; D A Gabriel; L M Aledort; D Green; C M Kessler
Journal:  Blood       Date:  1995-07-15       Impact factor: 22.113

Review 3.  Factor VIII inhibitors. Laboratory diagnosis of inhibitors.

Authors:  M A Sahud
Journal:  Semin Thromb Hemost       Date:  2000       Impact factor: 4.180

4.  Case report: successful use of antifibrinolytic therapy in acquired factor VIII deficiency.

Authors:  R B Lalwani; R B Stricker
Journal:  Am J Med Sci       Date:  1992-06       Impact factor: 2.378

5.  Pulmonary embolism associated with tranexamic acid in severe acquired haemophilia.

Authors:  Minakshi Taparia; Frank T Cordingley; Michael F Leahy
Journal:  Eur J Haematol       Date:  2002-05       Impact factor: 2.997
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.